 |
 |
 |
 |
 |
|
|
| Article 1 to 5 out of 5 concerning GlaxoSmithKline plc (GSK)
|
-
Researchers locate geographic origins from DNA
(05 Sep 2008)
One day soon, you may be able to pinpoint the geographic origins of your ancestors based on analysis of your DNA
A study published in Nature by an international team that included Cornell researchers describes the use of DNA to predict the geographic origins of individuals from a sample of Europeans, often within a few hundred kilometers of where they were ...
-
Thermo Fisher Scientific Extends Reach in India with Addition of Leading Laboratory Chemicals Supplier
(30 Jul 2007)
Thermo Fisher Scientific Inc. announced it has entered into an agreement to acquire Qualigens Fine Chemicals, a division of GlaxoSmithKline Pharmaceuticals Ltd. (GSK India) based in Mumbai. Qualigens is India's largest laboratory chemical ...
-
Out of REACH
(21 Nov 2006)
New legislation threatens medicines
Europe's proposed new chemicals legislation, REACH, could disrupt the supply of important medicines. David Vosvenieks, REACH issue manager at AstraZeneca (AZ), told Chemistry & Industry that two companies supplying intermediates required for two AZ ...
-
Structure of Human Cytochrome P450 2D6 solved by GlaxoSmithKline with the use of Fludigm Technology
(21 Mar 2006)
The TOPAZ® system for protein crystallization was instrumental in helping GlaxoSmithKline (GSK) solve the structure of cytochrome P450 2D6, an enzyme important in the metabolism of a wide variety of drugs. TOPAZ crystallization chips were used to ...
-
GlaxoSmithKline Biologicals and Aeras Global TB Vaccine Foundation Partner To Develop New TB Vaccine
(24 Oct 2005)
GlaxoSmithKline Biologicals (GSK Biologicals) and the Aeras Global TB Vaccine Foundation (Aeras) announced a new public-private partnership to develop GSK Biologicals' tuberculosis candidate vaccine Mtb72F/AS02A, which has shown promising results in ...
 |
|
|
|
|